Beck Bode, LLC Guardant Health, Inc. Transaction History
Beck Bode, LLC
- $529 Million
- Q3 2024
A detailed history of Beck Bode, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Beck Bode, LLC holds 248,859 shares of GH stock, worth $9.14 Million. This represents 1.08% of its overall portfolio holdings.
Number of Shares
248,859
Previous 269,390
7.62%
Holding current value
$9.14 Million
Previous $7.78 Million
26.65%
% of portfolio
1.08%
Previous 1.56%
Shares
8 transactions
Others Institutions Holding GH
# of Institutions
323Shares Held
127MCall Options Held
844KPut Options Held
2.38M-
Vanguard Group Inc Valley Forge, PA11.7MShares$430 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$413 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$372 Million0.04% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$254 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$220 Million5.07% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.75B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...